[Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT].
Medizinische Klinik I, Universitätsklinikum, RWTH Aachen, Pauwelstrasse 30, Aachen. dfrechen@ukaachen.de
D
D
Frechen
Y
Y
Temur
C
C
Cornelissen
S
S
Kweider
S
S
Krüger
D001706:Biopsy; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary; D018278:Carcinoma, Neuroendocrine / Q000000981:diagnostic imaging* / Q000473:pathology / Q000556:secondary; D019788:Fluorodeoxyglucose F18; D005710:Gallium Radioisotopes; D006801:Humans; D007089:Image Enhancement; D007090:Image Interpretation, Computer-Assisted; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging / Q000473:pathology; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging; D009367:Neoplasm Staging; D015282:Octreotide / Q000031:analogs & derivatives*; D049268:Positron-Emission Tomography; D012272:Ribs / Q000000981:diagnostic imaging / Q000473:pathology; D012447:Sacrum / Q000000981:diagnostic imaging / Q000473:pathology; D013125:Spinal Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary; D014057:Tomography, X-Ray Computed
D005710:Gallium Radioisotopes; D019788:Fluorodeoxyglucose F18; D015282:Octreotide; C106246:Edotreotide